The Israel (XTAE:ILCO) Research & Development: ₪205 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XTAE:ILCO The Israel Corp Ltd XTAE:ILCO
65 GF Score
Price ₪777.60
GF Value ₪886.07
Valuation Modestly Undervalued
! 5 Warning Signs
View Full Analysis

What is The Israel Research & Development?

The Israel XTAE:ILCO +0.76% 65 Research & Development is ₪205 Mil as of Mar. 2026. GuruFocus rates XTAE:ILCO with a GF Score™ of 65/100 and a GF Value™ of ₪886.07 (Modestly Undervalued). The stock has 5 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. The Israel's Research & Development for the three months ended in Mar. 2026 was ₪46 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 was ₪205 Mil.

The Israel  (XTAE:ILCO) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

The Israel Research & Development Related Terms

The Israel Research & Development Historical Data

* Premium members only.

The historical data trend for The Israel's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The Israel Research & Development Chart

The Israel Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 195.50 207.72 216.88 210.78 213.83

The Israel Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 54.99 58.04 48.88 51.93 45.82
XTAE:ILCO
65GF Score
The Israel Corp Ltd XTAE:ILCO
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

The Israel Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₪205 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of ₪205 Mil mean?
The Israel (XTAE:ILCO) has a Research & Development of ₪205 Mil as of Mar. 2026. Research and development expense is the total cost for research and development activities. View historical data on The Israel and its competitors.
Is The Israel's Research & Development too high?
The Israel's current Research & Development is ₪205 Mil. Overall, The Israel has a GF Score™ of 65/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does The Israel's Research & Development compare to LIN and SHW?
The Israel's Research & Development of ₪205 Mil can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Chemicals company?
A good Research & Development depends on the Chemicals industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on The Israel and its competitors. The Israel's current Research & Development is ₪205 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is The Israel stock overvalued right now?
Based on GuruFocus' analysis, The Israel (XTAE:ILCO) is currently considered Modestly Undervalued. The stock's GF Value™ is ₪886.07, compared to a current price of ₪777.60 — trading 12.2% below its estimated fair value. The current Research & Development is ₪205 Mil. The Israel's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For The Israel (XTAE:ILCO), the current Research & Development is ₪205 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is The Israel (XTAE:ILCO) Overvalued in 2026?

Based on GuruFocus' analysis, The Israel stock appears to be undervalued. The current stock price of ₪777.60 is trading 12.2% below its estimated GF Value™ of ₪886.07. GuruFocus considers The Israel to be Modestly Undervalued.

Key valuation signals for XTAE:ILCO:

  • Research & Development: ₪205 Mil
  • GF Value™: ₪886.07 vs. price of ₪777.60 (12.2% below fair value)
  • GF Score™: 65/100 with 5 warning signs

No single metric tells the full story. See the XTAE:ILCO stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

The Israel Business Description

Address 23 Aranha Street, P.O. Box 20456, Millennium Tower, Tel Aviv, ISR, 61204
The Israel Corp Ltd is a holding company. Along with its subsidiaries, it operates as a specialty minerals and chemicals company creating solutions to challenges in the food, agriculture, and industrial markets by leveraging its bromine, potash, and phosphate resources. The group operates through the following segments: Industrial Products (Bromine), Potash, Phosphate Solutions, and Growing Solutions. Maximum revenue is generated from its Phosphate Solutions segment, which manufactures phosphoric acid, sulphuric acid, green phosphoric acid, and phosphate fertilizers through its mines and facilities in Israel and China. Geographically, the group generates maximum revenue from Israel, followed by Europe, South America, North America, Asia, and other regions.
65GF Score

Get the complete analysis for XTAE:ILCO

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₪777.60
Price
₪886.07
GF Value